Patent - Abbreviated New Drug Application Cases filed in New Jersey
Cases 31 - 40 of 48
CHIESI USA, INC. et al v. AUROBINDO PHARMA USA, INC. et al
as 2:2019cv18756
Defendant: AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Plaintiff: CHIESI USA, INC. and CHIESI FARMACEUTICI S.p.A.
Cause Of Action: 35 U.S.C. § 271
CHIESI USA, INC. et al v. AUROBINDO PHARMA USA, INC. et al We have downloadable decisions or orders for this case
as 3:2019cv18756
Defendant: AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Plaintiff: CHIESI USA, INC. and CHIESI FARMACEUTICI S.P.A.
Cause Of Action: 35 U.S.C. § 271
ACTELION PHARMACEUTICALS LTD v. AUROBINDO PHARMA USA INC. et al
as 3:2019cv15437
Defendant: AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff: ACTELION PHARMACEUTICALS LTD
Cause Of Action: 15 U.S.C. § 1126
SENJU PHARMACEUTICAL CO., LTD et al v. AUROBINDO PHARMA USA INC. et al
as 3:2019cv13348
Defendant: AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff: SENJU PHARMACEUTICAL CO., LTD, BAUSCH & LOMB INCORPORATED and BAUSCH & LOMB PHARMA HOLDINGS CORP.
Cause Of Action: 35 U.S.C. § 271
ASTRAZENECA PHARMACEUTICALS LP et al v. AUROBINDO PHARMA LIMITED et al
as 3:2019cv12567
Defendant: AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff: ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED and ASTRAZENECA AB
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. AUROBINDO PHARMA LIMITED et al
as 3:2019cv08840
Plaintiff: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant: AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Cause Of Action: 15 U.S.C. § 1126
CELGENE CORPORATION v. AUROBINDO PHARMA LIMITED et al
as 2:2019cv05799
Defendant: AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LIMITED, AUROLIFE PHARMA LLC and others
Plaintiff: CELGENE CORPORATION
Cause Of Action: 15 U.S.C. § 1126
MEDA PHARMACEUTICALS INC. v. AUROBINDO PHARMA LIMITED et al
as 3:2019cv05501
Defendant: AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Plaintiff: MEDA PHARMACEUTICALS INC.
Cause Of Action: 28 U.S.C. § 1338
CELGENE CORPORATION v. AUROBINDO PHARMA LIMITED et al
as 2:2019cv00143
Defendant: AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LIMITED, AUROLIFE PHARMA LLC and others
Plaintiff: CELGENE CORPORATION
Cause Of Action: 15 U.S.C. § 1126
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. AUROBINDO PHARMA USA INC. et al
as 3:2018cv17733
Defendant: AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LTD.
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?